Annual Report 1998
Annual Report 1998
Annual Report 1998
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
44<br />
Board of Directors’ report *<br />
CHANGE IN SCA GROUP STRUCTURE<br />
In 1997 it was decided to establish a so-called Control Agreement<br />
between SCA and PWA, to be effective in <strong>1998</strong>. The<br />
Control Agreement creates conditions for implementing<br />
desired structural changes and facilitates the continuing integration<br />
of PWA and SCA. The integration measures that continued<br />
in <strong>1998</strong> included establishment of a common legal organization<br />
for hygiene-products operations. The packaging<br />
operations in PWA were also transferred to SCA Packaging.<br />
During the autumn the name of PWA AG was changed to SCA<br />
Hygiene Products AG.<br />
CAPITAL EXPENDITURES AND ACQUISITIONS<br />
In addition to current capital expenditures of SEK 2,058 M,<br />
strategic capital expenditures amounting to SEK 2,248 M were<br />
made during the year, with Hygiene Products accounting for<br />
SEK 1,617 M and Packaging for SEK 512 M. Projects within<br />
Hygiene Products include a new tissue machine and converting<br />
capacity for tissue in Mannheim, Germany, new capacity in the<br />
incontinence segment and establishment of new production<br />
technologies for baby diapers. The capital expenditure in<br />
Mannheim is estimated at SEK 1,400 M and is being carried<br />
out during the period <strong>1998</strong>–2000, with most activity in 1999.<br />
In the Packaging field, capital expenditures include rebuilding<br />
and new construction in Obbola, Sweden, and Witzenhausen,<br />
Germany, as well as new converting technology for corrugated<br />
board at several production plants.<br />
SCA’s acquisitions during <strong>1998</strong> and certain acquisition at<br />
the beginning of 1999 are presented below in the business area<br />
sections. In total, acquisitions in <strong>1998</strong> amounted to SEK<br />
2,793 M, including the additional purchase of PWA shares.<br />
As of 31 December <strong>1998</strong>, SCA held 96% of PWA’s shares.<br />
Hygiene Products<br />
Early in <strong>1998</strong> the Hygiene Products business area acquired<br />
Marpo, a Spanish tissue company with annual sales of approximately<br />
SEK 550 M. The purchase price was approximately<br />
six times Marpo’s 1997 operating profit.<br />
In Russia, SCA acquired all the shares of Svetogorsk Tissue<br />
for approximately SEK 200 M. Svetogorsk Tissue, which is<br />
located in the St. Petersburg region, has Russia’s most modern<br />
tissue machine, built in 1989.<br />
During <strong>1998</strong> the business area increased its holding in<br />
Productos Familia, a Colombian tissue company, to 50%,<br />
which in turn acquired all the shares of the Tecnopapel tissue<br />
company in Ecuador.<br />
Previously announced plans to acquire a shareholding in the<br />
Melhoramentos tissue company in Brazil have not yet been<br />
completed as a result of the financial uncertainty prevailing in<br />
the country.<br />
The business area also acquired three retailers of incontinence<br />
products in France with total annual sales of SEK<br />
140 M.<br />
Involvement in Asia was increased through acquisition of<br />
a Philippine tissue company. The purchase price was SEK<br />
130 M.<br />
Packaging<br />
In the beginning of <strong>1998</strong> the Packaging business area acquired<br />
a minority interest in the corrugated board operations of the<br />
Spanish company Lantero. SCA paid SEK 196 M for 25% of<br />
the share capital and has an option to increase its holding to<br />
49%.<br />
The business area will acquire a 49% interest in OBALEX,<br />
a Czech packaging company with annual sales of SEK 260 M.<br />
The acquisition is being made in two stages; 33% of the shares<br />
were acquired in <strong>1998</strong> and the remaining shares, up to 49% of<br />
the total, are being acquired in 1999. SCA has an option to buy<br />
the remaining shares.<br />
In the beginning of 1999 the corrugated board division of<br />
Rexam Plc was acquired. The purchase price was approximately<br />
SEK 2,600 M, equal to about 6.5 times the operating<br />
surplus and about 9 times the operating profit, based on estimated<br />
results for <strong>1998</strong>. The business has sales of approximately<br />
SEK 2,700 M. The acquisition increases SCA’s share of the<br />
market for corrugated board in Great Britain from 13% to<br />
21%, and from 13% to 14% in Europe.<br />
Danapak Papemballage, the third largest packaging company<br />
in Denmark, was acquired in January 1999 for SEK<br />
636 M. The purchase price corresponds to eight times operating<br />
profit for <strong>1998</strong>. <strong>Annual</strong>ly, the company produces about<br />
100 million m 2 of corrugated board and has sales of SEK<br />
650 M.<br />
During <strong>1998</strong> the business area acquired all shares outstanding<br />
in the Widmer-Walty Group in Switzerland.<br />
In early 1999, SCA acquired an 11% interest in a Singapore-based<br />
packaging company for SEK 36 M. SCA has the<br />
possibility of increasing ownership to 51% within five years.<br />
The company produces about 50 million m 2 of corrugated<br />
board annually.<br />
Graphic Paper<br />
During <strong>1998</strong>, Graphic Paper acquired additional shares in<br />
Laarkirchen AG for SEK 44 M. Currently, compulsory redemption<br />
is under way of the remaining shares. The remaining<br />
purchase amount, SEK 54 M, will be paid during the first quarter<br />
of 1999.<br />
DIVESTMENTS<br />
SCA divested the Clinical Products business unit (surgical and<br />
wound-care products) in the beginning of <strong>1998</strong>. The sale<br />
amounted to approximately SEK 1,500 M, resulting in a<br />
capital gain of SEK 400 M, which was reported during the first<br />
quarter of <strong>1998</strong>.<br />
RESTRUCTURING<br />
The integration of the Group’s tissue and fluff operations is<br />
continuing. SCA’s plants in the hygiene sector in France are<br />
* In addition to these pages, the Board of Directors’ report includes the discussions and analyses accompanying the cash flow statement, statement of earnings and balance<br />
sheet (pages 46, 48 and 50).